COPD News Today

Focusing on education, action for this year’s COPD Awareness Month

November marks COPD Awareness Month, and advocates this year will focus on action, and education about chronic obstructive ...
COPD News Today

Learning firsthand about the risk of shingles with COPD

Columnist Caroline Gainer explains the risk of developing shingles for people with COPD, who often have weakened immune ...
copdnewstoday

Phase 3 trial testing benralizumab in COPD patients misses main goal

A Phase 3 clinical trial testing AstraZeneca’s injection therapy benralizumab as a potential treatment for chronic obstructive pulmonary disease (COPD) has failed to meet its main goal of showing the ...
copdnewstoday

My experiences with COPD and inflammation aren’t cut-and-dried

Those of us living with chronic obstructive pulmonary disease (COPD) have learned to pay close attention to subtle changes in our bodies to avoid or quickly address respiratory infections, which can ...
copdnewstoday

Hydration and guaifenesin help keep my airway clear

Note: This column describes the author’s own experiences with guaifenesin. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. We always ...
copdnewstoday

‘Stay busy. Be useful.’ is a great mantra for those living with COPD

I recently read an article on my newsfeed that said Arnold Schwarzenegger, bodybuilder, actor, and onetime California governor, had a four-word mantra: “Stay busy. Be useful.” I thought this was a ...
copdnewstoday

2 global trials show mixed results for astegolimab for treating COPD

Genentech has announced mixed top-line results from two global clinical trials testing its treatment candidate astegolimab in people with moderate to very severe chronic obstructive pulmonary disease ...
copdnewstoday

FDA approves Nucala as add-on therapy for certain COPD patients

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain people with chronic obstructive pulmonary disease (COPD). The treatment, ...
copdnewstoday

Vaping with e-cigarettes associated with higher COPD risk

Using e-cigarettes, often called vaping, significantly increases the risk of chronic obstructive pulmonary disease (COPD), a U.S. study suggests. People who used e-cigarettes, which are ...
copdnewstoday

FDA approves first RSV vaccine for at-risk adults younger than 50

The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...
copdnewstoday

Low climate-impact inhalers as effective as pressurized ones: Study

Dry-powder corticosteroid inhalers, or those designed to have a low impact on climate, are as effective as those based on pressurized, metered doses at reducing the risk of poor outcomes in people ...